Fengate announces equity investment in GraceMed

November 19, 2021

Fengate Private Equity (“Fengate”), a division of Fengate Asset Management, is pleased to announce it has completed a strategic minority equity investment in the Grace Clinics Corp. (“GraceMed”). Fengate’s investment in GraceMed was made on behalf of the LiUNA Pension Fund of Central and Eastern Canada. GraceMed’s management and existing shareholders will continue to retain a significant equity interest in the business.

Founded in 2019 by Dr. Douglas Grace, a renowned cosmetic surgeon with more than 18 years of experience, GraceMed has become a recognized leader in the fields of plastic and cosmetic surgery, dermatology, and medical aesthetics in Canada. GraceMed features an experienced team of world-class practitioners who provide clients with a comprehensive range of aesthetic procedures, medical-grade skincare, and cosmetic surgeries while utilizing the latest medical technology and techniques.

As a best-in-class, physician-led platform, GraceMed has become a “partner of choice” for operators across Canada’s fragmented cosmetic surgery and medical spa industries. GraceMed has quickly grown its clinic network of top-ranked locations across the GTA and Southwestern Ontario. The new investment partnership with Fengate will provide GraceMed with additional growth capital and strategic support.

“This strategic partnership aligns perfectly with our mission to support the needs and aspirations of growth-oriented entrepreneurs and businesses,” said Justin Catalano, Managing Director and Group Head of Fengate Private Equity. “We are pleased to be an investment partner to GraceMed and believe in Doug and his team. We are excited to work closely with GraceMed to accelerate the next stage of their growth.”

“Today’s announcement reflects the vision, hard work and unwavering commitment of always providing best in class service, safety and outcomes to our patients by our physicians, nurses, aestheticians and team at GraceMed.” said Dr. Douglas Grace, MD, FRCS(C), CEO and founder of GraceMed. “We are honoured to partner with Justin and his team at Fengate Private Equity. This strategic alliance will enable us to continue to pursue our vision of being Canada’s leading provider of Aesthetic Medicine.”

Related Posts

  • November 25, 2024
    Fengate and Alpha Omega Power achieve financial close on 400MWh battery storage project in California
  • Tavares IRF in Florida
    November 5, 2024
    Fengate announces financial close on two U.S. healthcare facilities
  • Fengate P3 Awards
    October 28, 2024
    Fengate celebrates dual wins at P3 Awards
  • BAND Offsite
    October 22, 2024
    LiUNA and Fengate collaboration gives emerging artists a platform in Toronto